Untapped diamonds for untamed diabetes: The α-glucosidase inhibitors

about

Acarbose plus metformin fixed-dose combination in the management of type 2 diabetes.Therapeutic potential of α-glucosidase inhibitors in type 2 diabetes mellitus: an evidence-based review.

P2860

Q38223104-2E81D8D9-246A-42CF-8459-8C2ACE9CEF80 Q38563239-D042C593-B128-4A4E-90DD-6C4350722673

P2860

Untapped diamonds for untamed diabetes: The α-glucosidase inhibitors

Item

http://www.wikidata.org/entity/Q37703682

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Untapped diamonds for untamed diabetes: The α-glucosidase inhibitors

@en

Untapped diamonds for untamed diabetes: The α-glucosidase inhibitors.

@nl

type

Item

label

Untapped diamonds for untamed diabetes: The α-glucosidase inhibitors

@en

Untapped diamonds for untamed diabetes: The α-glucosidase inhibitors.

@nl

prefLabel

Untapped diamonds for untamed diabetes: The α-glucosidase inhibitors

@en

Untapped diamonds for untamed diabetes: The α-glucosidase inhibitors.

@nl

P1476

Untapped diamonds for untamed diabetes: The α-glucosidase inhibitors

@en

P2093

A G Unnikrishnan

http://www.w3.org/2001/XMLSchema#string

Manoj Chadha

http://www.w3.org/2001/XMLSchema#string

S K Sharma

http://www.w3.org/2001/XMLSchema#string

P2860

Standards of medical care in diabetes--2013

Safety and efficacy of acarbose in the treatment of Type 2 diabetes: data from a 5-year surveillance study.

Are the effects of alpha-glucosidase inhibitors on cardiovascular events related to elevated levels of hydrogen gas in the gastrointestinal tract?

Second-line therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy: a systematic review and mixed-treatment comparison meta-analysis.

Alpha-glucosidase inhibitors for patients with type 2 diabetes: results from a Cochrane systematic review and meta-analysis.

Critical evaluation of the role of acarbose in the treatment of diabetes: patient considerations.

Effects of 24-week treatment with acarbose on glucagon-like peptide 1 in newly diagnosed type 2 diabetic patients: a preliminary report.

Addressing the burden of type 2 diabetes and cardiovascular disease through the management of postprandial hyperglycaemia: an Asian-Pacific perspective and expert recommendations.

A prospective, parallel group, open-labeled, comparative, multi-centric, active controlled study to evaluate the safety, tolerability and benefits of fixed dose combination of acarbose and metformin versus metformin alone in type 2 diabetes.

AACE comprehensive diabetes management algorithm 2013.

P304

138-141

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.4103/2230-8210.129102

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sanjay Kalra

P577

2014-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24741507

http://www.w3.org/2001/XMLSchema#string

P932

3987261

http://www.w3.org/2001/XMLSchema#string

Untapped diamonds for untamed diabetes: The α-glucosidase inhibitors

about

P2860

P2860

Untapped diamonds for untamed diabetes: The α-glucosidase inhibitors

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P932